Founder Peter Rahal has characterized the lawsuit as frivolous, arguing the company's labels comply with FDA regulations and that plaintiffs' testing methodology is flawed. Rahal contends the independent labs measured combustion energy rather than digestible calories, inflating results. A consultant from FTC International Consulting has corroborated this position, stating the testing method was inappropriate and David Protein's labeling is accurate.
The case carries particular weight given Rahal's track record: he co-founded RxBar, which Kellogg's acquired for $600 million in 2017 before he launched David Protein in September 2024. Beyond the calorie dispute, the company has also faced social media backlash tied to Rahal's past associations. Separately, three competing snack makers have filed an antitrust complaint alleging David Protein has excluded competitors and created an artificial monopoly in the protein bar segment.
Attorneys should monitor this litigation closely as it tests the boundaries of FDA nutrition labeling standards and the evidentiary weight of independent lab testing in consumer fraud cases. The outcome will likely influence how courts evaluate competing methodologies for measuring caloric content and may reshape labeling practices across the protein supplement industry.